Charterhouse eyes possible $1.1 billion sale of UK medical company Tunstall: Reuters

British private equity firm Charterhouse is working with JP Morgan (JPM.N) on options for healthcare company Tunstall, in a deal which could value the company at up to 700 million pounds ($1.1 billion), Reuters News reported.

DealsNorth AmericaUSBriefs